Past and future evolution in colloidal drug delivery systems.
Colloidal drug delivery systems have been providing alternative formulation approaches for problematic drug candidates, and improved delivery for existing compounds for decades. Colloidal systems for drug delivery have all evolved down a similar pathway, almost irrespective of the delivery system, from conception, to the use of safer excipients, PEGylation for passive targeting and attachment of ligands for active targeting. The recent emergence of truly biologically interactive systems represents the latest step forward in colloidal delivery systems. In this article, the maturation pathway and recent advances for the major classes of colloidal delivery systems are reviewed, and the paper poses the question of whether the nanotechnology boom will create a revolution in colloidal delivery, or just the next natural stage in evolution.
Boyd
Ben J
BJ
Department of Pharmaceutics, Victorian College of Pharmacy - Monash University, 381 Royal Pde, Parkville, VIC, 3052, Australia. ben.boyd@vcp.monash.edu.au
D000818:Animals; D003102:Colloids / Q000008:administration & dosage* / Q000737:chemistry; D050091:Dendrimers; D016503:Drug Delivery Systems / Q000379:methods / Q000639:trends; D004655:Emulsions; D006801:Humans; D008823:Micelles; D053758:Nanoparticles; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*
D003102:Colloids; D050091:Dendrimers; D004655:Emulsions; D008823:Micelles; D004364:Pharmaceutical Preparations